These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26458464)

  • 1. [Neutrophil disorders: diagnosis and hematopoietic stem cell transplantation].
    Kobayashi M
    Rinsho Ketsueki; 2015 Oct; 56(10):2230-9. PubMed ID: 26458464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders.
    Elloumi HZ; Holland SM
    Methods Mol Biol; 2007; 412():505-23. PubMed ID: 18453131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor.
    Leung AY; Tse E; Hwang YY; Chan TS; Gill H; Chim CS; Lie AK; Kwong YL
    Am J Hematol; 2013 Jun; 88(6):485-91. PubMed ID: 23512868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning.
    Tsuma Y; Imamura T; Ichise E; Sakamoto K; Ouchi K; Osone S; Ishida H; Wada T; Hosoi H
    Pediatr Transplant; 2015 Feb; 19(1):E25-8. PubMed ID: 25412586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.
    Ayas M; Nassar A; Hamidieh AA; Kharfan-Dabaja M; Othman TB; Elhaddad A; Seraihy A; Hussain F; Alimoghaddam K; Ladeb S; Fahmy O; Bazarbachi A; Mohamed SY; Bakr M; Korthof E; Aljurf M; Ghavamzadeh A
    Bone Marrow Transplant; 2013 Sep; 48(9):1168-72. PubMed ID: 23542225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
    Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
    Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
    Nash RA
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic stem cell transplantation for autoimmune disorders.
    Saccardi R; Di Gioia M; Bosi A
    Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
    Oyama Y; Traynor AE; Barr W; Burt RK
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
    Coleman MA; Steptoe RJ
    Autoimmun Rev; 2012 Dec; 12(2):195-203. PubMed ID: 23047179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
    Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
    Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of liver dysfunction before transplantation and during conditioning period on the outcome of allogeneic hematopoietic stem cell transplantation].
    Zhao J; Ren H; Qiu Z; Wang M; Liu W; Xu W; Li Y; Sun Y; Wang L; Liang Z; Dong Y; Ou J; Wang W; Yin Y; Cen X; Wang Q
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):99-103. PubMed ID: 24767159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
    Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
    Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders.
    Elloumi HZ; Holland SM
    Methods Mol Biol; 2014; 1124():517-35. PubMed ID: 24504972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.